If your depression keeps hanging on despite treatment, you’re not alone. At least 30% of people treated for depression don’t get adequate relief from their first antidepressant, and when researchers use stricter definitions of recovery, that number climbs to roughly 55%. The reason your depression won’t go away is rarely about willpower or doing something wrong. More often, it’s because something specific is being missed: an underlying medical condition, the wrong type of therapy, a genetic factor affecting how your body processes medication, or a co-occurring condition that nobody has identified yet.
What Treatment-Resistant Depression Actually Means
Clinically, depression is considered “treatment-resistant” after you’ve tried at least one antidepressant at an adequate dose for an adequate length of time without meaningful improvement. Some definitions require two failed trials. Either way, the label doesn’t mean your depression is permanent or untreatable. It means the first approach didn’t work, and the search for the right one needs to get more specific.
That search often involves looking beyond the depression itself. Persistent depression frequently has roots that standard treatment wasn’t designed to reach, whether those roots are biological, psychological, or hiding in a completely different diagnosis.
Inflammation May Be Working Against Your Medication
One of the more significant findings in depression research is the role of chronic, low-grade inflammation. Your body produces a protein called C-reactive protein (CRP) as part of its inflammatory response, and people with depression tend to have higher CRP levels than people without it. More importantly, people with treatment-resistant depression have even higher levels than those who respond well to medication.
Studies consistently show that patients with elevated CRP are less likely to reach remission on standard antidepressants, particularly SSRIs. People with lower inflammation levels tend to respond faster and more completely. This matters because inflammation can stem from a range of everyday sources: poor sleep, chronic stress, a sedentary lifestyle, gut health issues, or autoimmune conditions. If inflammation is fueling your depression, an antidepressant alone may not be enough to turn things around. Addressing the inflammatory source, whether through exercise, dietary changes, or treating an underlying condition, can make medication more effective.
A Genetic Variant That Blocks Your Brain Chemistry
Your body needs to convert folate (vitamin B9) into its active form before your brain can use it to produce serotonin, dopamine, and norepinephrine, the chemicals most antidepressants target. An enzyme called MTHFR handles that conversion. Some people carry a genetic variant that makes this enzyme sluggish or partially nonfunctional, which means their brain may not produce enough of these chemicals regardless of what medication they take.
This is a meaningful finding for people whose depression doesn’t budge with treatment. If your body can’t efficiently convert folate into its usable form, supplementing with standard folic acid won’t help much either, because folic acid still requires that same broken conversion step. The workaround is L-methylfolate, the already-converted form that can cross into the brain directly, bypassing the faulty enzyme entirely. Genetic testing through a simple blood test or saliva kit can reveal whether you carry this variant. It’s an underused but straightforward piece of the puzzle.
Medical Conditions That Mimic or Fuel Depression
Several common medical conditions produce symptoms that look exactly like depression, and if they go undiagnosed, no amount of antidepressant therapy will fully resolve what you’re feeling.
Thyroid dysfunction is one of the most frequent culprits. Both overactive and underactive thyroid function are linked to persistent depressive symptoms. Research from the Mayo Clinic found that people with low levels of free T4 (the active thyroid hormone) had 58% higher odds of chronic, recurring depression compared to those with normal levels. Abnormal thyroid-stimulating hormone levels, whether too high or too low, carried similar risks. A standard blood panel can catch this, but it’s not always ordered during a psychiatric evaluation.
Obstructive sleep apnea is another overlooked driver. When your breathing repeatedly stops during sleep, the resulting oxygen drops and sleep fragmentation create fatigue, difficulty concentrating, irritability, and low mood, a profile that overlaps almost entirely with major depression. Research confirms that undiagnosed sleep apnea can make antidepressants ineffective, and most clinicians don’t suspect it early on. If you snore heavily, wake up unrefreshed despite adequate hours of sleep, or have been told you stop breathing at night, a sleep study is worth pursuing.
Undiagnosed ADHD Hiding Behind Depression
Adult ADHD is one of the sneakiest conditions that can masquerade as treatment-resistant depression. In a study of women with recurrent depression, nearly 13% had elevated ADHD symptoms significant enough to flag on clinical screening. Not a single one of them had ever been diagnosed with ADHD by a medical professional.
This matters because ADHD and depression share several features: difficulty concentrating, low motivation, trouble following through on tasks, and a sense of underperformance that erodes self-worth over time. If the core problem is actually ADHD, treating it as depression alone will keep falling short. ADHD requires its own set of interventions, and when it’s properly addressed, the “depression” that seemed untreatable often improves substantially.
When Your Therapy Type Doesn’t Match Your History
Cognitive behavioral therapy (CBT) is the most commonly recommended psychotherapy for depression, and it works well for many people. But it doesn’t work equally well for everyone, and the reason may depend on your personal history.
A study published in The British Journal of Psychiatry followed people with chronic depression through five years of either CBT or psychoanalytic therapy. For people with low levels of childhood trauma, both therapies produced similar improvements. But for people who reported higher levels of childhood trauma, the difference was striking: those in psychoanalytic therapy (a longer-term, deeper approach focused on early relational patterns) improved significantly more than those in CBT. CBT’s structured, present-focused techniques may not reach the deeper relational wounds that keep depression locked in place for trauma survivors.
If you experienced neglect, abuse, or significant instability in childhood and haven’t seen progress with CBT, this doesn’t mean therapy doesn’t work for you. It may mean you need a different kind. Psychodynamic therapy, EMDR, or other trauma-focused approaches can access what standard CBT wasn’t built to address.
Newer Options With Real Evidence Behind Them
If you’ve tried multiple medications and therapy approaches without relief, two newer treatments have shown meaningful results specifically for treatment-resistant depression.
Repetitive transcranial magnetic stimulation (rTMS) uses targeted magnetic pulses to stimulate underactive areas of the brain. In clinical trials, it produced a response rate of about 50% and remission in roughly 30% of treatment-resistant patients. It’s noninvasive, done in an outpatient setting, and involves daily sessions over several weeks.
Esketamine, a nasal spray derived from ketamine and used alongside a new oral antidepressant, has shown even higher numbers: approximately 70% response and 50% remission in treatment-resistant patients. It’s administered in a clinical setting where you’re monitored for a couple of hours after each dose, typically twice a week initially and then tapering. Both treatments represent a genuine step forward for people who haven’t found relief through conventional medication, and both are now widely available through specialty clinics.
Building a More Complete Picture
When depression won’t budge, the instinct is often to try another antidepressant or increase the dose. Sometimes that works. But persistent depression frequently signals that something beyond a simple chemical imbalance is at play, and the most effective path forward involves systematically ruling out what else might be contributing.
A practical starting point: ask about bloodwork that covers thyroid function, inflammatory markers like CRP, and folate levels. Mention any symptoms that could point to sleep apnea or ADHD. If you have a history of childhood trauma, bring that up in the context of whether your current therapy approach is the right fit. Each of these represents a concrete, testable factor that could explain why your current treatment isn’t working, and each one has a specific solution once identified.
Depression that resists treatment isn’t a dead end. It’s almost always a signal that the diagnostic picture is incomplete.